BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Neocentromeres
,
Doxycycline
,
rs2300478
,
LEP
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
abelson
Summary
General Info
Curated Studies
Most Correlated Studies
Mammary tumor MVT-1 cells treated with insulin
Embryonic testis of F1,F2,and F3 progeny of vinclozolin-treated dams
Prostate gene expression in F3 descendents of rats treated with the endocrine disruptor vinclozolin
Anti-Mullerian hormone to inhibit primordial to primary follicle transition in the rat ovary
Brains of rats three generations removed from vinclozolin exposure
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenou…
Ponatinib: An update on its drug targets, therapeutic potential and safety.
Effect of D-mannose on Philadelphia chromosome-positive leukemia cells.
Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging…
Management of chronic myeloid leukemia presenting with isolated thrombocytosis and complex Philadelp…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic …
Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characte…
Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
TKI Discontinuation in CML Patients of China
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ